LSD-based tablet shows promise in new anxiety trial

A late-stage clinical trial by Definium Therapeutics found that a single dose of its experimental LSD-based tablet provided rapid, sustained relief for adults with Generalized Anxiety Disorder. Dr. Saundra Maass-Robinson, a principal investigator with CenExel-Atlanta, joined us on "The Nine" to break down the clinical science behind the potential breakthrough.